Artery first: The ARTERY FIRST Approach for Resection of Pancreatic Head Cancer

Sponsor
Heidelberg University (Other)
Overall Status
Unknown status
CT.gov ID
NCT01332773
Collaborator
(none)
124
1
2
16
7.8

Study Details

Study Description

Brief Summary

To show whether the artery first approach leads to equal or less rate of positive resection margins in pancreatic head cancer than the standard technique (ppWhipple only with standard Kocher's manoeuvre)

Condition or Disease Intervention/Treatment Phase
  • Procedure: Artery first procedure
  • Procedure: No artery first procedure
Phase 3

Detailed Description

This is a prospective non-randomized trial with two study groups. The trial is designed to show if the ARTERY FIRST approach reduces the rate of R1 resections in patients undergoing surgery for cancer of the pancreatic head.

After the diagnosis of cancer of the pancreatic head by clinical, laboratory and imaging evaluation patients who are scheduled for resection will be screened for inclusion into the trial. Informed consent is obtained at least on the day before surgery and patients meeting the eligibility criteria will be enrolled into the study.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
124 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The ARTERY FIRST Approach for Resection of Pancreatic Head Cancer
Study Start Date :
Mar 1, 2010
Anticipated Primary Completion Date :
Jul 1, 2011
Anticipated Study Completion Date :
Jul 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Experimental: Artery first group

The basic principle of the "artery first" approach is the early identification of the SMA at its origin at the aorta with the further resection then being guided by its anatomic course. The dissection is carried cephalad along the aorta until the origin of the SMA is reached. The posterior and right aspect of the SMA is then dissected over a few centimeters. On the right side of the SMA a replaced or accessory right hepatic artery, if present, will be identified and preserved. This maneuver should be done, if infiltration of the SMA is suspected as the procedure can be terminated at this point. Once the situation at the SMA is assessed and resectability is confirmed resection will be done.

Procedure: Artery first procedure
early identification of SMA to evaluate infiltration

Active Comparator: Conventional Group

A wide Kocher manoeuver is performed to fully mobilize the duodenum and the head of the pancreas. The colonic mesentery on the right side is separated from the anterior surface of the duodenum and the head of the pancreas. The size of the tumor and its relation to the superior mesenteric artery, the celiac trunk, the mesentery, the portal vein, and the superior mesenteric vein is assessed. If resectability is given a Kausch-Whipple's resection is performed.

Procedure: No artery first procedure
conventional exposure and preparation (Kocher's manoeuvre) before transection of pancreatic parenchyma

Outcome Measures

Primary Outcome Measures

  1. Rate of R1 resections [up to 1.5 years]

    positive resection margins as described by the pathologists of the University of Heidelberg

Secondary Outcome Measures

  1. Exploratory analyses [up to 1.5 years]

    Exploratory analyses of frequencies of complications and serious adverse events

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Pancreatic head cancer (diagnosis by clinical, laboratory and radiological evaluation)

  • Patients scheduled for curative resection

  • No evidence of distant metastases

  • Age equal or greater than 18 years

  • Informed consent

Exclusion Criteria:
  • Expected lack of compliance

  • Impaired mental state or language problems

  • patient having had neoadjuvant radiochemotherapy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of General, Visceral and Transplantation Surgery, University of Heidelberg Heidelberg Baden-Württemberg Germany 69120

Sponsors and Collaborators

  • Heidelberg University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01332773
Other Study ID Numbers:
  • NNR-7
First Posted:
Apr 11, 2011
Last Update Posted:
Apr 19, 2011
Last Verified:
Dec 1, 2009
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 19, 2011